Podcast
Drug Pricing and Market Access: CMS Update With Rujul Desai
May 13, 2026
Senior Counselor to CMS, Rujul Desai, joins the Latham team to share updates on a host of current policy topics, from most favored nation pricing and TrumpRx to 340B and program integrity initiatives.
The Trump administration has advanced many policy initiatives in the drug pricing and market access area, and CMS — the Centers for Medicare & Medicaid Services — is the agency at the heart of many of these efforts. Rujul Desai, Senior Counselor to CMS and former Deputy General Counsel at the Department of Health & Human Services, joins Washington, D.C. partner Chris Schott and associate Danny Machado for an update on key CMS priorities. Rujul also discusses the transition from big law to government and shares practice pointers for engaging with the agency.
Listen here or subscribe via Apple Podcasts, Spotify, or anywhere else you listen to podcasts.